Surrogate endpoints in heart failure: (once again) use with caution.

about

Surrogate endpoints in heart failure: (once again) use with caution.

Item

http://www.wikidata.org/entity/Q53838113

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Surrogate endpoints in heart failure: (once again) use with caution.

@en

Surrogate endpoints in heart failure:

@nl

type

Item

label

Surrogate endpoints in heart failure: (once again) use with caution.

@en

Surrogate endpoints in heart failure:

@nl

prefLabel

Surrogate endpoints in heart failure: (once again) use with caution.

@en

Surrogate endpoints in heart failure:

@nl

P1476

Surrogate endpoints in heart failure: (once again) use with caution.

@en

P2093

Georgios Giannopoulos

http://www.w3.org/2001/XMLSchema#string

Spyridon Deftereos

http://www.w3.org/2001/XMLSchema#string

Vasiliki Panagopoulou

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.

Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib

Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.

The role of renin angiotensin system blockade in the treatment of atrial fibrillation.

A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease.

Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial.

Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial.

Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical Trials.

β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.

P304

563-565

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1002/EJHF.770

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gerasimos Filippatos

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28371139

http://www.w3.org/2001/XMLSchema#string

P921

heart failure